About Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
Clinical Trials at Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
During the past decade, Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "ERIC Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
According to Clinical.Site data, the most researched conditions in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo" are
"Non-Hodgkin's Lymphoma" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Hodgkin Lymphoma" (2 trials) and "AML, Adult" (1 trials). Many other conditions were trialed in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo" in a lesser frequency.
Clinical Trials Intervention Types at Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
Most popular intervention types in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo" are "Drug" (21 trials), "Combination Product" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "Doxorubicin" (2 trials), "Lenalidomide" (2 trials), "Venetoclax" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
The vast majority of trials in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo" are
26 trials for "All" genders.
Clinical Trials Status at Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo
Currently, there are NaN active trials in "Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo".
2 are not yet recruiting,
11 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".